Abstract

The enrichment of specific intronic splicing enhancers upstream of weak PY tracts suggests a novel mechanism for intron recognition that compensates for a weakened canonical pre-mRNA splicing motif.

Highlights

  • While the current model of pre-mRNA splicing is based on the recognition of four canonical intronic motifs (5' splice site, branchpoint sequence, polypyrimidine (PY) tract and 3' splice site), it is becoming increasingly clear that splicing is regulated by both canonical and noncanonical splicing signals located in the RNA sequence of introns and exons that act to recruit the spliceosome and associated splicing factors

  • We present results showing that G-rich and C-rich motifs, similar to those predicted by our computational approach to be enriched upstream of weak PY tracts, are intronic splicing enhancer (ISE) important for the splicing of lecithin cholesterol acyltransferase (LCAT) intron 4, which has a weak PY tract

  • Visual inspection of human introns reveals that, the PY tract region is enriched in uridines in general, there is a great deal of sequence variation between introns

Read more

Summary

Introduction

While the current model of pre-mRNA splicing is based on the recognition of four canonical intronic motifs (5' splice site, branchpoint sequence, polypyrimidine (PY) tract and 3' splice site), it is becoming increasingly clear that splicing is regulated by both canonical and noncanonical splicing signals located in the RNA sequence of introns and exons that act to recruit the spliceosome and associated splicing factors. Genome Biology 2008, Volume 9, Issue 6, Article R97 Murray et al R97.2 introns and exons. This is underlined by the observation that incorrect pre-mRNA splicing is a major contributor to human genetic diseases [4,5,6]. Is splicing a crucial step in the accurate transfer of genetic information from DNA to RNA to protein, it is a step that allows for regulation of gene expression as well as increased protein diversity through alternative splicing decisions [7]

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.